Key result
Pharmacologic inhibition of cell contractility or genetic deletion of smooth muscle cell focal adhesion kinase reduced circumferential arterial stiffness and vessel wall thickness in mice.
Why the study?
The direct contributions of vascular smooth muscle cell contractility and mechanosensors to arterial stiffness and the arterial response to pressure remain incompletely understood.
Smooth muscle cell contractility and focal adhesion kinase are key regulators of circumferential arterial stiffness and wall thickness, providing mechanistic insights into vascular biomechanics.
SMC mechanosensors may modulate pressure-induced stiffness; leaves open clinical translation to human hypertension.
Arterial stiffening is a hallmark of aging and cardiovascular disease. While it is well established that vascular smooth muscle cells (SMCs) contribute to arterial stiffness by synthesizing and remodeling the arterial extracellular matrix, the direct contributions of SMC contractility and mechanosensors to arterial stiffness, and particularly the arterial response to pressure, remain less well understood despite being a long-standing question of biomedical importance. Here, we have examined this issue by combining the use of pressure myography of intact carotid arteries, pharmacologic inhibition of contractility, and genetic deletion of SMC focal adhesion kinase (FAK). Biaxial inflation-extension tests performed at physiological pressures showed that acute inhibition of cell contractility with blebbistatin or EGTA altered vessel geometry and preferentially reduced circumferential, as opposed to axial, arterial stiffness in wild-type mice. Similarly, genetic deletion of SMC FAK, which attenuated arterial contraction to KCl, reduced vessel wall thickness and circumferential arterial stiffness in response to pressure while having minimal effect on axial mechanics. Moreover, these effects of FAK deletion were lost by treating arteries with blebbistatin or by inhibiting myosin light-chain kinase. The expression of arterial fibrillar collagens, the integrity of arterial elastin, or markers of SMC differentiation were not affected by the deletion of SMC FAK. Our results connect cell contractility and SMC FAK to the regulation of arterial wall thickness and directionally specific arterial stiffening.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (2022) studied Arterial stiffness. Pharmacologic inhibition of contractility and genetic deletion of SMC FAK vs. Wild-type / untreated arteries was evaluated on Circumferential arterial stiffness and vessel wall thickness. Pharmacologic inhibition of cell contractility or genetic deletion of smooth muscle cell focal adhesion kinase reduced circumferential arterial stiffness and vessel wall thickness in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: